Email
Wechat
Facebook
@shhqcbd
Twitter
@shhqcbd
TicTok
@shhqcbd
Hongqiao Focus
Home > Hongqiao Focus>Updates

Parkway Shanghai Hospital partners up with Stem Cell Group

LMS
en.shhqcbd.gov.cn| Updated: July 29, 2025

10.jpg

Parkway Hospital and China Stem Cell Group sign a cooperation agreement. [Photo/cntock.com]

Parkway Shanghai Hospital — which is part of the IHH Healthcare Group — recently partnered up with the Stem Cell Hospital of the China Stem Cell Group to advance medical research and healthcare services.  

Located in the Shanghai New Hongqiao International Medical Park, Parkway Shanghai Hospital is known for its international-standard medical services.  

By combining China Stem Cell Group's expertise in stem cells with Parkway's high-end medical capabilities, the partnership will focus on cutting-edge medical research and clinical applications.

Together, they plan to support the "Healthy China" strategy — developing comprehensive medical solutions for disease prevention, diagnosis and rehabilitation, concentrating on major disease prevention and precise health management.  

The collaboration also aims to boost Shanghai's status as a biopharmaceutical innovation hub, enhancing the city's healthcare landscape.

Top News

Hongqiao Intl CBD unveils plan to boost live streaming

China's key progress in 14th Five-Year Plan period

Advanced air mobility products make global debuts at Shanghai expo

Most Requested
Business in Hongqiao
CIIE
Transportation hub
YRD
BACK TO THE TOP
Copyright© Shanghai Hongqiao
International Central Business District.
All Rights Reserved. Presented by China Daily.